Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19
Open Access
- 19 May 2020
- journal article
- case report
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (9), 1383-1387
- https://doi.org/10.1016/j.jaccas.2020.05.017
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- COVID-19 may transmit through aerosolIrish Journal of Medical Science, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Low left ventricular outflow tract velocity time integral is associated with poor outcomes in acute pulmonary embolismVascular Medicine, 2019
- Right Ventricular Outflow Doppler Predicts Low Cardiac Index in Intermediate Risk Pulmonary EmbolismClinical and Applied Thrombosis/hemostasis, 2019
- Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary EmbolismCirculation, 2014
- Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial)The American Journal of Cardiology, 2013
- Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary HypertensionCirculation, 2011
- Clinical, historical and diagnostic findings associated with right ventricular dysfunction in patients with central and non-massive pulmonary embolismInternal and Emergency Medicine, 2009